Phibro Animal Health (PAHC) Revenue Growth (5y) (2017 - 2026)
Phibro Animal Health (PAHC) Revenue Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.62% |
| Dec 31, 2025 | 12.65% |
| Sep 30, 2025 | 13.27% |
| Jun 30, 2025 | 15.29% |
| Mar 31, 2025 | 10.54% |
| Dec 31, 2024 | 7.64% |
| Sep 30, 2024 | 6.54% |
| Jun 30, 2024 | 6.03% |
| Mar 31, 2024 | 5.05% |
| Dec 31, 2023 | 2.75% |
| Sep 30, 2023 | 2.94% |
| Jun 30, 2023 | 3.79% |
| Mar 31, 2023 | 3.30% |
| Dec 31, 2022 | 3.51% |
| Sep 30, 2022 | 3.75% |
| Jun 30, 2022 | 5.55% |
| Mar 31, 2022 | 4.77% |
| Dec 31, 2021 | 3.96% |
| Sep 30, 2021 | 2.69% |
| Jun 30, 2021 | 3.09% |